UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~November~~December 1721, 2020

Grow Capital, Inc.

(Exact name of Registrant as specified in its charter)

Nevada	000-53548	86-0970023
(State or other Jurisdiction of Incorporation or organization)	(Commission File Number)	(IRS Employer I.D. No.)

2485 Village View Drive, Suite 180
Henderson, NV 89074
Phone: (702) 830-7919
(Address, including zip code, and telephone number, including area code, of
registrant’s principal executive offices)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)

☐ Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	n/a	n/a

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]

Item 8.01 Other Events

OnAs previously disclosed, on November 17, 2020, Grow Capital, Inc. (“we,” “us,” “our,” “Grow” or the “Company”) filed a Notification of Late Filing with the Securities and Exchange Commission ("SEC') on Form 12b-25 pertaining to its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 (the "10-Q"). Due to the complexity of the accounting issues arising out of businesses recently acquired, the Company iswas unable to timely file the 10-Q within the 5-day extension period afforded to the Company by filing the Form 12b-25.

~~Our~~The ~~first~~Company ~~quarter~~previously ~~10-Q~~anticipated ~~is a complex~~ filing ~~because~~its ~~our~~first ~~recent~~quarter ~~acquisitions~~10-Q ~~require~~prior us to ~~analyze~~ the 45 day cure ~~Company’s~~period ~~variable~~granted ~~interests,~~under ~~including~~OTCQB ~~equity~~rules. ~~investments~~However, todespite ~~determine if~~ the ~~Company~~diligent ~~has~~efforts ~~any~~of ~~variable~~its ~~interests~~personnel, inconsultants ~~variable~~and ~~interest~~auditors, ~~entities. Generally~~and ~~accepted~~due ~~accounting principles (“GAAP”) require a reporting entity~~ to ~~consolidate~~the acomplexity ~~variable interest~~of ~~entity when~~ the ~~reporting~~10-Q ~~entity~~as ~~has~~previously adisclosed ~~variable~~and ~~interest~~described ~~that~~below, ~~provides it with a controlling interest in~~ the ~~variable~~Company ~~interest~~will ~~entity.~~not ~~The~~be ~~entity~~able ~~that consolidates a variable interest entity is referred~~ to asfile the ~~primary beneficiary of that~~10-Q ~~variable~~within ~~interest~~the ~~entity. The~~original ~~Company~~45 ~~and~~day ~~its~~extension ~~auditors~~of ~~have~~OTCQB ~~determined,~~eligibility ~~due~~granted toby OTC. Therefore, the ~~recent~~Company ~~acquisitions,~~has ~~that~~requested ~~certain~~an additional ~~related~~extension ~~entities~~of ~~are~~time ~~variable~~to ~~interest~~complete ~~entities~~its ofoutstanding 10-Q which ~~Grow~~has isbeen ~~the~~granted ~~primary~~by ~~beneficiary,~~the ~~and~~OTC. During ~~therefore~~this ~~GAAP~~cure ~~requires~~period, the Company ~~consolidation~~may ofcontinue ~~the~~to ~~variable~~be ~~interest~~traded ~~entities~~on ~~with~~ the ~~financial~~OTCQB ~~statements of Grow~~market. ~~Because~~ ofThe ~~the~~Company ~~extensive~~expects ~~process necessary~~ to ~~compile~~file ~~this~~its ~~information~~first ~~for~~quarter ~~SEC~~Form ~~reporting,~~10-Q weon ~~are~~or ~~delaying~~before ~~our~~February ~~10-Q~~1, ~~filing~~2021.

~~Due~~As previously disclosed, our first quarter 10-Q is a complex filing because our recent acquisitions require us to analyze the ~~delayed~~Company’s ~~filing~~variable interests, ~~the~~including ~~company~~equity ~~expects~~investments, to determine if the ~~OTCQB~~Company has any variable interests in variable interest entities. Generally accepted accounting principles (“GAAP”) require a reporting entity to ~~display~~consolidate a ~~notification~~variable interest entity when the reporting entity has a variable interest that provides it with a controlling interest in the ~~Company~~variable interest entity. The entity that consolidates a variable interest entity is isreferred ~~delinquent~~to inas ~~its~~the ~~SEC~~primary ~~periodic~~beneficiary ~~reporting~~of ~~requirements.~~that variable interest entity. The Company ~~anticipates~~and ~~filing~~ its ~~first~~auditors ~~quarter~~have ~~10-Q~~determined, ~~prior~~due to the 45recent ~~day~~acquisitions, ~~cure~~that ~~period~~certain ~~granted~~additional ~~under~~related ~~OTCQB~~entities ~~rules. During~~are ~~this~~variable ~~cure~~interest ~~period~~entities of which Grow is the primary beneficiary, and therefore GAAP requires the ~~Company~~consolidation ~~may~~of ~~continue~~the tovariable beinterest ~~traded~~entities onwith the ~~OTCQB market~~financial statements of Grow.

The Company has been diligently working with its reporting consultants and auditors to obtain all the required supporting data and process the very large amount of financial information. Due to several factors including the sheer volume of the information required to be analyzed and the timeline it is taking to obtain all necessary support from much larger operating entities, further complicated by the impact of COVID-19 on the Company the Company requested an additional thirty (30) day extension of OTC eligibility in which to complete the necessary data analysis and file the pending report on Form 10-Q and Form 8-K which has been granted by the OTC. The Company has been assured by its consultants, auditors and relevant personnel that this work will be completed in time to enable the filing of the delinquent 10-Q for the three months ended September 30, 2020 by January 31, 2021.

SIGNATURE PAGE

Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Grow Capital, Inc.

By: /s/ Terry Kennedy

Terry Kennedy
Chief Executive Officer

Dated: ~~November~~December 1821, 2020

Filing Compare · GROW CAPITAL, INC.